Utsumi, T.; Suzuki, H.; Wakatsuki, M.; Kobayashi, K.; Okato, A.; Nakajima, M.; Aoki, S.; Sumiya, T.; Ichikawa, T.; Akakura, K.;
et al. Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy. Appl. Sci. 2025, 15, 804.
https://doi.org/10.3390/app15020804
AMA Style
Utsumi T, Suzuki H, Wakatsuki M, Kobayashi K, Okato A, Nakajima M, Aoki S, Sumiya T, Ichikawa T, Akakura K,
et al. Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy. Applied Sciences. 2025; 15(2):804.
https://doi.org/10.3390/app15020804
Chicago/Turabian Style
Utsumi, Takanobu, Hiroyoshi Suzuki, Masaru Wakatsuki, Kana Kobayashi, Atsushi Okato, Mio Nakajima, Shuri Aoki, Taisuke Sumiya, Tomohiko Ichikawa, Koichiro Akakura,
and et al. 2025. "Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy" Applied Sciences 15, no. 2: 804.
https://doi.org/10.3390/app15020804
APA Style
Utsumi, T., Suzuki, H., Wakatsuki, M., Kobayashi, K., Okato, A., Nakajima, M., Aoki, S., Sumiya, T., Ichikawa, T., Akakura, K., Tsuji, H., Yamada, S., & Ishikawa, H.
(2025). Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy. Applied Sciences, 15(2), 804.
https://doi.org/10.3390/app15020804
